(Q36671734)

15 August 2017

Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment (English)

1 reference

15 August 2017

1 reference

C Rubino

1

1 reference

15 August 2017

F de Vathaire

2

1 reference

15 August 2017

A Shamsaldin

3

1 reference

15 August 2017

M Labbe

4

1 reference

15 August 2017

M G Lê

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

89

1 reference

15 August 2017

5

1 reference

15 August 2017

840-846

1 reference

Second primary cancers following breast cancer in the Japanese female population

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Second primary cancers following female breast cancer in Osaka, Japan--a population-based cohort study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Second neoplasms after adjuvant chemotherapy for operable breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Dose distribution throughout the body from radiotherapy for Hodgkin's disease in childhood.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Statistical methods in cancer research. Volume I - The analysis of case-control studies.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394476

Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

20 September 2018

1 reference

12 December 2020

Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer

1 reference

12 December 2020

[The role of the medical corps in a mass screening program for cervical cancer. The program "Female Health Action in 3 urban districts of Lyons]

1 reference

12 December 2020

Tamoxifen and risk of large bowel cancer in women with breast cancer

1 reference

12 December 2020

Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan

1 reference

12 December 2020

Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors

1 reference

12 December 2020

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1 reference

12 December 2020

Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment

1 reference

12 December 2020

Second cancer following cancer of the breast in Connecticut, 1935-82

1 reference

12 December 2020

Second malignancies after CMF for resectable breast cancer

1 reference

12 December 2020

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

1 reference

12 December 2020

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy

1 reference

12 December 2020

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

12 December 2020

Second cancers after adjuvant tamoxifen therapy for breast cancer

1 reference

12 December 2020

Increased risk of second cancers following breast cancer: role of the initial treatment

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601138

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

12942115

1 reference